Studies on AD transgenic animal models have shown that XBP1 is linked to ADAM10 transcriptional regulation; ADAM10 (ADAM Metallopeptidase Domain 10) is the main α-secretase that cleaves APP [74]. Here, ADAM10 is linked to Alzheimer disease.